Profound Medical CorpNASDAQ:PROFView on Canadian Exchange
- LAST PRICE8.7500
- TODAY'S CHANGE (%)-0.2100 (-2.3438%)
- Bid / Lots8.3500/ 2
- Ask / Lots9.1700/ 4
- Open / Previous Close9.0000 / 8.9600
- Day Range
- 52 Week Range
- Volume80,466
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PROF |
|---|---|---|
| 09:32 ET | 1900 | 8.8 |
| 09:33 ET | 1418 | 8.17 |
| 09:35 ET | 100 | 8.37 |
| 09:37 ET | 734 | 8.58 |
| 09:39 ET | 100 | 8.58 |
| 09:42 ET | 1928 | 8.77 |
| 09:50 ET | 127 | 8.8 |
| 09:51 ET | 1820 | 9.0383 |
| 09:57 ET | 900 | 8.785 |
| 10:00 ET | 1600 | 8.79 |
| 10:02 ET | 1000 | 8.785 |
| 10:04 ET | 200 | 8.79 |
| 10:08 ET | 4000 | 8.71 |
| 10:11 ET | 2100 | 8.691423 |
| 10:13 ET | 2000 | 8.5701 |
| 10:22 ET | 4167 | 8.655 |
| 10:29 ET | 2125 | 9.17 |
| 10:31 ET | 100 | 9.15 |
| 10:33 ET | 3100 | 9.1041 |
| 10:47 ET | 350 | 9.0779 |
| 10:56 ET | 800 | 8.9584 |
| 11:09 ET | 409 | 8.95 |
| 11:38 ET | 1000 | 8.83 |
| 11:43 ET | 1700 | 8.71 |
| 11:45 ET | 400 | 8.645 |
| 11:54 ET | 933 | 8.645 |
| 11:59 ET | 600 | 8.645 |
| 12:01 ET | 100 | 8.64 |
| 12:08 ET | 10791 | 8.98 |
| 12:10 ET | 242 | 8.905 |
| 12:21 ET | 300 | 8.956 |
| 12:28 ET | 100 | 8.95 |
| 12:37 ET | 100 | 8.925 |
| 12:57 ET | 1500 | 8.9 |
| 01:04 ET | 800 | 8.8 |
| 01:09 ET | 211 | 8.825 |
| 01:11 ET | 100 | 8.825 |
| 01:15 ET | 150 | 8.8288 |
| 01:18 ET | 9900 | 8.65 |
| 01:31 ET | 180 | 8.65 |
| 01:49 ET | 200 | 8.5813 |
| 01:58 ET | 1000 | 8.7299 |
| 02:03 ET | 315 | 8.645 |
| 02:18 ET | 1200 | 8.6736 |
| 02:20 ET | 500 | 8.64 |
| 02:21 ET | 100 | 8.69 |
| 02:23 ET | 2574 | 8.72 |
| 02:41 ET | 100 | 8.71 |
| 02:48 ET | 100 | 8.73 |
| 02:54 ET | 500 | 8.82 |
| 02:57 ET | 100 | 8.8899 |
| 03:03 ET | 200 | 8.86 |
| 03:06 ET | 200 | 8.77 |
| 03:10 ET | 500 | 8.87 |
| 03:24 ET | 500 | 8.77 |
| 03:26 ET | 500 | 8.77 |
| 03:35 ET | 1598 | 8.62 |
| 03:37 ET | 500 | 8.61 |
| 03:48 ET | 114 | 8.685 |
| 03:50 ET | 198 | 8.61 |
| 03:51 ET | 250 | 8.68 |
| 03:53 ET | 100 | 8.63 |
| 04:00 ET | 2005 | 8.75 |
Nov 7, 2024
Profound Medical Announces Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 4, 2024
Oct 17, 2024
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 -- Conference Call to Follow, from 4:30PM ET on Thursday Oct 17, 2024 by Dow Jones
4:30PM ET on Thursday Oct 17, 2024 by Dow Jones
Oct 16, 2024
*DJ Profound Medical Appoints Tom Tamberrino as Chief Comml Officer, from 4:17PM ET on Wednesday Oct 16, 2024 by Dow Jones
4:17PM ET on Wednesday Oct 16, 2024 by Dow JonesProfound Medical Appoints Tom Tamberrino as Chief Commercial Officer, from 4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Profound Medical Corp | 295.4M | 0.0x | --- |
Company Information
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Contact Information
- Headquarters
- 2400 Skymark Ave Unit 6MISSISSAUGA, ON, Canada L4W 5K5
- Phone
- 647-476-1350
- Fax
- 647-476-1350
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $295.4M |
|---|---|
Revenue (TTM) | $11.0M |
Shares Outstanding | 24.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.91 |
EPS | $-1.69 |
Book Value | $2.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 27.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -389.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
